<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:department>Unlisted</gtr:department><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/EED2CDE3-9C5C-4C6C-A4E3-2ABBEE591634"><gtr:id>EED2CDE3-9C5C-4C6C-A4E3-2ABBEE591634</gtr:id><gtr:firstName>Behdad</gtr:firstName><gtr:surname>Afzali</gtr:surname><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0500429"><gtr:id>8E7D7BC0-DC05-4431-BE09-B6DEC05D9E22</gtr:id><gtr:title>Does cognate specificity enhance the efficacy of regulatory T cells</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G0500429</gtr:grantReference><gtr:abstractText>Kidney transplants between individuals with differing genetic makeup are rejected rapidly without large doses of powerful drugs to suppress the immune system. But with time transplants may require lower amounts of immunosuppression to prevent rejection - this is known as transplant tolerance. A subpopulation of immune cells (recognised by the fact they are CD4 and CD25 surface marker positive) has been implicated as playing a central role in the regulation of this tolerance. These regulatory cells have been shown to be able to confer tolerance to a transplant after being infused into a another, non-tolerant, animal. They therefore have potential to be used to prevent rejection of transplants in humans.

Understanding of how regulatory cells work has improved recently - it was thought that they only responded to portions of proteins antigens) derived from the transplanted graft. Now it is clearly known that they can recognise other proteins as well. This project proposes to investigate the function of regulatory cells to see if they confer tolerance only in the presence of their antigens. We plan to set up experiments in which regulatory cells will be used to suppress rejection in the presence or absence of their antigens. The outcome of this project could have implications for future human immunosuppressive therapy.</gtr:abstractText><gtr:technicalSummary>The morbidity and mortality associated with prolonged pharmacological immunosuppression is one of the major limitations in modern day organ transplantation. Recent insights into the phenotype and function of regulatory T cells (Tregs) have opened up new possibilities for promoting transplantation tolerance, and reducing the burden of drug-based immunosuppression. Data from experimental and clinical studies suggest that the major immunological driver of chronic transplant rejection is the indirect alloresponse, in which MHC alloantigens are recognised in peptide form, presented by MHC class II molecules on recipient antigen-presenting cells. Consequently, it is this, indirect, pathway of allorecognition that is the most important target for immune regulation.
T lymphocytes that constitutively co-express CD4 and CD25 have been shown in mouse and man to have dedicated regulatory function and normally serve to prevent autoimmune disease. Furthemore, it appears that it is this cell population that is responsible for maintaining transplantation tolerance in experimental models and in man. One of the most contentious issues surrounding CD4+CD25+ Tregs concerns their specificity. We reason that these cells are capable of allospecificity, and hypothesise that enrichment for anti-donor allospecificity will greatly increase the potency of their suppressive effects in preventing transplant rejection.
This hypothesis will be tested in two ways. In a mouse system, an indirect allospecificity will be conferred on purified, cultured CD4+CD25+ Treg cells by retroviral transduction of T cell receptor genes encoding a receptor specific for a peptide of a mouse MHC class 1 molecule (H2-Kd) presented 
By the H2-Ab class II molecule. Transduced cells will be selected by magnetic beads or flow cytometry, and compared in potency to mock-transduced (purely autoantigen-specific) Tregs. In vitro functional assays will be performed alongside in vivo adoptive transfer experiments using skin and heart graft survival as readouts. In vivo trafficking will also be examined using CFSE-labelled cells. Parallel experiments will be conducted in a human in vitro system. Based on recent success in expanding allospecific human CD4+CD25+ Tregs using peptide-pulsed autologous dendritic antigen-presenting cells, HLA-DR1:A2, and HLA-DR15:A2 peptide tetramers will be used to stain and to select regulatory cell lines with indirect allospecificity for A2. Allospecific cells will be compared with unselected polyclonal Tregs for their efficacy in suppressing alloresponses in vitro. 
These experiments will inform the design of strategies for the exploitation of CD4+CD25+ Tregs in the promotion of clinical tolerance, and will determine whether selection of antigen-specificity is a necessary step in such protocols.</gtr:technicalSummary><gtr:fund><gtr:end>2009-01-16</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2005-10-17</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>239105</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>King's College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Medicine KCL</gtr:department><gtr:description>Dr Susan John, Department of Immunobiology, King's College London</gtr:description><gtr:id>37D93700-3849-4F38-896F-C2D79C0CCB06</gtr:id><gtr:impact>Data from this collaboration has been presented at two national and two international conferences. We have published one article and are about to submit another.</gtr:impact><gtr:outcomeId>6E9E36288CE-1</gtr:outcomeId><gtr:partnerContribution>Intellectual contributions including study design and technical support and supervision of experiments; data analysis and interpretation.</gtr:partnerContribution><gtr:piContribution>Intellectual input, experimental design and collaborative research.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>King's College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Medicine KCL</gtr:department><gtr:description>Prof Ghulam Mufti</gtr:description><gtr:id>C86ECEA5-9F34-44C9-B001-9E4E59008716</gtr:id><gtr:impact>This collaboration has resulted in three publications (19210506, 19491336 and 17412885) and presentations at international conferences.</gtr:impact><gtr:outcomeId>7A1D3F8416C-1</gtr:outcomeId><gtr:partnerContribution>Intellectual input, study design, provision of samples and technical support.</gtr:partnerContribution><gtr:piContribution>Intellectual input, study design, experimental work, data analysis and interpretation.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>King's College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Medicine KCL</gtr:department><gtr:description>Dr Timothy Tree, King's College London</gtr:description><gtr:id>2CAF0D3B-8F43-46F2-9FCB-6F2795291EE2</gtr:id><gtr:impact>Data from this collaboration will be published in the near future as two separate manuscripts. Preliminary data has been presented at conferences.</gtr:impact><gtr:outcomeId>8048EEE913E-1</gtr:outcomeId><gtr:partnerContribution>Intellectual input, experimental design and technical support.</gtr:partnerContribution><gtr:piContribution>Intellectual input, experimental design and collaborative research.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>King's College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Centre for Transplantation</gtr:department><gtr:description>Prof Graham Lord</gtr:description><gtr:id>820F1045-BB12-4D65-B80D-F3B7E00E4801</gtr:id><gtr:impact>One paper has already been published. Two more are under review</gtr:impact><gtr:outcomeId>M66pJ3srcX5-1</gtr:outcomeId><gtr:partnerContribution>Intellectual, materials and methods, data analysis and publication</gtr:partnerContribution><gtr:piContribution>Intellectual input, materials and methods, data analysis and publication</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Division of Infection and Immunity</gtr:department><gtr:description>Prof Bodo Grimbacher</gtr:description><gtr:id>4928B090-A4FE-4E18-ABDA-F3D05C5C083B</gtr:id><gtr:impact>Data from this work has been presented at two international conferences and will be submitted for publication shortly.</gtr:impact><gtr:outcomeId>00361537295-1</gtr:outcomeId><gtr:partnerContribution>Intellectual input, experimental design and provision of sample materials.</gtr:partnerContribution><gtr:piContribution>Intellectual input, experimental design and collaborative research.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>30000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Are ex vivo expanded human regulatory T cells safe and efficacious in pre-clinical models of human allograft rejection?</gtr:description><gtr:end>2012-09-02</gtr:end><gtr:fundingOrg>Academy of Medical Sciences (AMS)</gtr:fundingOrg><gtr:id>8B6023F7-4EEF-4341-8528-832024A15D85</gtr:id><gtr:outcomeId>CBRFo1b9pgi0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>61618</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Characterisation of the most suitable circulating Treg sub-populations in patients with advanced kidney disease for their use in cell therapy to induce transplant tolerance (DPFS devolved award)</gtr:description><gtr:end>2011-03-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>7EC942A1-2483-4FEB-8933-45A1E6F9DA5F</gtr:id><gtr:outcomeId>mesyxU2fdNW0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>313000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Impact of Vitamin D supplementation on Left Ventricular Mass on Cardiac Magnetic Resonance Imaging and Immune Regulation in Chronic Kidney Disease - A randomised placebo controlled trial (Guy's and St Thomas' NHS Foundation Trust Charity)</gtr:description><gtr:end>2013-12-02</gtr:end><gtr:fundingOrg>Guy?s &amp; St Thomas? Charity</gtr:fundingOrg><gtr:id>E4DA8339-A00E-454E-994E-920D6037D41E</gtr:id><gtr:outcomeId>PN8Vu3qscSK0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>75000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Genomic and phenotypic profiling of human regulatory T cells for cell therapy in transplantation (NIHR Biomedical Research Centre Strategic Initiative Call)</gtr:description><gtr:end>2011-03-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>C560FE2C-C644-4BE8-B98A-6AB667814D3A</gtr:id><gtr:outcomeId>fpRUP6uRkqz0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2010-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>A6276E84-50EA-48C3-ABE6-7F4907856BE8</gtr:id><gtr:title>Pathways of major histocompatibility complex allorecognition.</gtr:title><gtr:parentPublicationTitle>Current opinion in organ transplantation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a24f02668e536a6d0df0cd985e178d88"><gtr:id>a24f02668e536a6d0df0cd985e178d88</gtr:id><gtr:otherNames>Afzali B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1087-2418</gtr:issn><gtr:outcomeId>AA03595A775</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8FF1996C-8C24-428A-8321-00CB47AFBAE3</gtr:id><gtr:title>Intercellular transfer of MHC and immunological molecules: molecular mechanisms and biological significance.</gtr:title><gtr:parentPublicationTitle>American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/785928b8c34d6342ea641ff5256e80f7"><gtr:id>785928b8c34d6342ea641ff5256e80f7</gtr:id><gtr:otherNames>Smyth LA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1600-6135</gtr:issn><gtr:outcomeId>BE2A038B850</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1AF89057-8DD8-4E72-AA72-F2D2F6468984</gtr:id><gtr:title>Diabetes, kidney disease and anaemia: time to tackle a troublesome triad?</gtr:title><gtr:parentPublicationTitle>International journal of clinical practice</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/434d19d45ea83eef29c72976fa01972c"><gtr:id>434d19d45ea83eef29c72976fa01972c</gtr:id><gtr:otherNames>Al-Khoury S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1368-5031</gtr:issn><gtr:outcomeId>91EB7D3CEFD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F892EDDE-365F-4404-BAB3-999906CA4705</gtr:id><gtr:title>Differential effects of rapamycin and retinoic acid on expansion, stability and suppressive qualities of human CD4(+)CD25(+)FOXP3(+) T regulatory cell subpopulations.</gtr:title><gtr:parentPublicationTitle>Haematologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a501a6a9751751d9907ecb97f8214a5f"><gtr:id>a501a6a9751751d9907ecb97f8214a5f</gtr:id><gtr:otherNames>Scott? C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0390-6078</gtr:issn><gtr:outcomeId>pm_15195_25_23242600</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>90B8455E-D632-46D9-8378-022F07E2D319</gtr:id><gtr:title>Comparison of regulatory T cells in hemodialysis patients and healthy controls: implications for cell therapy in transplantation.</gtr:title><gtr:parentPublicationTitle>Clinical journal of the American Society of Nephrology : CJASN</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a24f02668e536a6d0df0cd985e178d88"><gtr:id>a24f02668e536a6d0df0cd985e178d88</gtr:id><gtr:otherNames>Afzali B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1555-9041</gtr:issn><gtr:outcomeId>pm_15195_25_23580782</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3DFE8A9B-9E7E-4C50-84BE-C6621B178DA7</gtr:id><gtr:title>What we CAN do about chronic allograft nephropathy: role of immunosuppressive modulations.</gtr:title><gtr:parentPublicationTitle>Kidney international</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a24f02668e536a6d0df0cd985e178d88"><gtr:id>a24f02668e536a6d0df0cd985e178d88</gtr:id><gtr:otherNames>Afzali B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0085-2538</gtr:issn><gtr:outcomeId>046EA4613FA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CF55E36A-21E7-42FD-B0BA-C6ECE2D6B40F</gtr:id><gtr:title>The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease.</gtr:title><gtr:parentPublicationTitle>Clinical and experimental immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a24f02668e536a6d0df0cd985e178d88"><gtr:id>a24f02668e536a6d0df0cd985e178d88</gtr:id><gtr:otherNames>Afzali B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0009-9104</gtr:issn><gtr:outcomeId>2D5A99CB9FC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2358EA54-B5F6-4F76-BD82-023E78DE5DC6</gtr:id><gtr:title>Cell therapy to promote transplantation tolerance: a winning strategy?</gtr:title><gtr:parentPublicationTitle>Immunotherapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1cc75691dbb514909ad66036a04b718e"><gtr:id>1cc75691dbb514909ad66036a04b718e</gtr:id><gtr:otherNames>Lombardi G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1750-743X</gtr:issn><gtr:outcomeId>KThvxBnGKbo</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4710A113-0069-41DC-B807-3A98BC48546C</gtr:id><gtr:title>Relative roles of Th1 and Th17 effector cells in allograft rejection.</gtr:title><gtr:parentPublicationTitle>Current opinion in organ transplantation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5612980a3fff3de4ff661b27748cd3f5"><gtr:id>5612980a3fff3de4ff661b27748cd3f5</gtr:id><gtr:otherNames>Atalar K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1087-2418</gtr:issn><gtr:outcomeId>ADA367FF3A3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5985A45D-04FA-4022-BB25-6AF6E690CE60</gtr:id><gtr:title>Helicobacter pylori induces in-vivo expansion of human regulatory T cells through stimulating interleukin-1? production by dendritic cells.</gtr:title><gtr:parentPublicationTitle>Clinical and experimental immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3f8caf6bb1e8b53c636a561310a37dca"><gtr:id>3f8caf6bb1e8b53c636a561310a37dca</gtr:id><gtr:otherNames>Mitchell PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0009-9104</gtr:issn><gtr:outcomeId>fNohHRzLxGU</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A7B428FB-3638-4FBA-AB4E-8B26619A1571</gtr:id><gtr:title>Long-term risks of increased use of intravenous iron.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a24f02668e536a6d0df0cd985e178d88"><gtr:id>a24f02668e536a6d0df0cd985e178d88</gtr:id><gtr:otherNames>Afzali B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>192344272A0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1D6FDC73-4EB8-4F5D-9AD9-ACFEEB5946B1</gtr:id><gtr:title>Posttransplantation anemia in adult renal allograft recipients: prevalence and predictors.</gtr:title><gtr:parentPublicationTitle>Transplantation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5d2ca8a192f59b7a25d7e50dd662d984"><gtr:id>5d2ca8a192f59b7a25d7e50dd662d984</gtr:id><gtr:otherNames>Shah N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0041-1337</gtr:issn><gtr:outcomeId>05F4207E2C5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C1BDCB7E-269E-4FCB-BAB6-89BF7105F2B5</gtr:id><gtr:title>Anti-TNFalpha therapy--killing two birds with one stone?</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0ed5af2af987cc926606c0d6b7fdb8f9"><gtr:id>0ed5af2af987cc926606c0d6b7fdb8f9</gtr:id><gtr:otherNames>Arif S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>bTVsfYHsptW</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>38C9BB88-E7FF-4615-9056-5B8DC1B62415</gtr:id><gtr:title>Relative resistance of human CD4(+) memory T cells to suppression by CD4(+) CD25(+) regulatory T cells.</gtr:title><gtr:parentPublicationTitle>American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a24f02668e536a6d0df0cd985e178d88"><gtr:id>a24f02668e536a6d0df0cd985e178d88</gtr:id><gtr:otherNames>Afzali B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1600-6135</gtr:issn><gtr:outcomeId>jkLR51va8pb</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>22160CAB-387B-474E-A427-E278289218BC</gtr:id><gtr:title>Post-transplantation anaemia in adult and paediatric renal allograft recipients-Guy's Hospital experience.</gtr:title><gtr:parentPublicationTitle>Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/434d19d45ea83eef29c72976fa01972c"><gtr:id>434d19d45ea83eef29c72976fa01972c</gtr:id><gtr:otherNames>Al-Khoury S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0931-0509</gtr:issn><gtr:outcomeId>5DDE0541887</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>41014374-723C-413E-A298-546243AAB825</gtr:id><gtr:title>Bleeding post coronary artery bypass surgery. Clopidogrel--cure or culprit?</gtr:title><gtr:parentPublicationTitle>Le Journal medical libanais. The Lebanese medical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f96149af2e2d9ef3bf86dfa5f61e0520"><gtr:id>f96149af2e2d9ef3bf86dfa5f61e0520</gtr:id><gtr:otherNames>Haydar AA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0023-9852</gtr:issn><gtr:outcomeId>BE22365350A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ABFFD60A-43A2-4E5E-A4F3-6F2ACEA35C65</gtr:id><gtr:title>Imbalance of effector and regulatory CD4 T cells is associated with graft-versus-host disease after hematopoietic stem cell transplantation using a reduced intensity conditioning regimen and alemtuzumab.</gtr:title><gtr:parentPublicationTitle>Haematologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/25389bf512d2e8d62b76aa21e3f84902"><gtr:id>25389bf512d2e8d62b76aa21e3f84902</gtr:id><gtr:otherNames>Matthews K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0390-6078</gtr:issn><gtr:outcomeId>4499D89C8EF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E30B7BE9-CE81-4331-9F72-6105739BCCB2</gtr:id><gtr:title>T-cell alloimmunity and chronic allograft dysfunction.</gtr:title><gtr:parentPublicationTitle>Kidney international. Supplement</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f8f79b3b082d0af0f2cd8470d59b7efb"><gtr:id>f8f79b3b082d0af0f2cd8470d59b7efb</gtr:id><gtr:otherNames>Safinia N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0098-6577</gtr:issn><gtr:outcomeId>qXMcojgvZeT</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>54FE6922-4E70-4929-8BE9-DE91B906BDAF</gtr:id><gtr:title>Anaemia in diabetic patients with chronic kidney disease--prevalence and predictors.</gtr:title><gtr:parentPublicationTitle>Diabetologia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/434d19d45ea83eef29c72976fa01972c"><gtr:id>434d19d45ea83eef29c72976fa01972c</gtr:id><gtr:otherNames>Al-Khoury S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0012-186X</gtr:issn><gtr:outcomeId>60431168E06</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6306BF25-7C06-4E03-8F0B-4A9409996277</gtr:id><gtr:title>IL-2 regulates expression of C-MAF in human CD4 T cells.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d4bd41f5e795706d066b9db464defb69"><gtr:id>d4bd41f5e795706d066b9db464defb69</gtr:id><gtr:otherNames>Rani A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>cRwrhHbC2At</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B7625687-8946-4FED-AEDD-C3E28D46ECD5</gtr:id><gtr:title>The maintenance of human CD4+ CD25+ regulatory T cell function: IL-2, IL-4, IL-7 and IL-15 preserve optimal suppressive potency in vitro.</gtr:title><gtr:parentPublicationTitle>International immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/97161852bd6fc0b913e94b2886e96f1d"><gtr:id>97161852bd6fc0b913e94b2886e96f1d</gtr:id><gtr:otherNames>Yates J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0953-8178</gtr:issn><gtr:outcomeId>83B39B2915A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AAB2E820-91AF-4960-8EF6-8EEDB18AB747</gtr:id><gtr:title>IL-17-producing CD4(+) T cells, pro-inflammatory cytokines and apoptosis are increased in low risk myelodysplastic syndrome.</gtr:title><gtr:parentPublicationTitle>British journal of haematology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1b47da750ef442cb5eafd80487cbf4e9"><gtr:id>1b47da750ef442cb5eafd80487cbf4e9</gtr:id><gtr:otherNames>Kordasti SY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0007-1048</gtr:issn><gtr:outcomeId>252DD29064F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>62ECD135-3D8C-4978-A9B7-C7B17D9BC9AF</gtr:id><gtr:title>The T helper 17-regulatory T cell axis in transplant rejection and tolerance.</gtr:title><gtr:parentPublicationTitle>Current opinion in organ transplantation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/42efcedd0dc9c06e83d06fa56f48575f"><gtr:id>42efcedd0dc9c06e83d06fa56f48575f</gtr:id><gtr:otherNames>Mitchell P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1087-2418</gtr:issn><gtr:outcomeId>410237896FE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F122FB8C-FE10-44A2-AB27-48BF8417CDD8</gtr:id><gtr:title>CD161 expression characterizes a subpopulation of human regulatory T cells that produces IL-17 in a STAT3-dependent manner.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a24f02668e536a6d0df0cd985e178d88"><gtr:id>a24f02668e536a6d0df0cd985e178d88</gtr:id><gtr:otherNames>Afzali B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>pm_15195_25_23677517</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>21DA2528-A438-4377-9964-FE9DA6B8F716</gtr:id><gtr:title>Oxford Textbook of Clinical Nephrology</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d06ae86334bc2d4b87d4c9f906001ca4"><gtr:id>d06ae86334bc2d4b87d4c9f906001ca4</gtr:id><gtr:otherNames>Khavandi K, Amer H, Withers S, Afzali B</gtr:otherNames></gtr:author></gtr:authors><gtr:isbn>978-0198508244</gtr:isbn><gtr:outcomeId>fQmHmnStD2r</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DC10EC2E-5F1B-4003-BC9D-91168A09E4CA</gtr:id><gtr:title>Falls, hypokalaemia, and a dry mouth.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5612980a3fff3de4ff661b27748cd3f5"><gtr:id>5612980a3fff3de4ff661b27748cd3f5</gtr:id><gtr:otherNames>Atalar K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>4487309F56E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>85964664-FE5F-451E-82BF-27D539EF6CA3</gtr:id><gtr:title>Assessment of regulatory T-cell function in forthcoming clinical trials of cell therapy.</gtr:title><gtr:parentPublicationTitle>Expert review of molecular diagnostics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/106c16d6f9893f7a7d87dd13518ba4f7"><gtr:id>106c16d6f9893f7a7d87dd13518ba4f7</gtr:id><gtr:otherNames>Canavan JB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1473-7159</gtr:issn><gtr:outcomeId>JFaDMxHPVGm</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E686DA0F-75FC-4C80-99F9-1BA7C60ED880</gtr:id><gtr:title>A rapid diagnostic test for human regulatory T-cell function to enable regulatory T-cell therapy.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/106c16d6f9893f7a7d87dd13518ba4f7"><gtr:id>106c16d6f9893f7a7d87dd13518ba4f7</gtr:id><gtr:otherNames>Canavan JB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>pm_15195_25_22219224</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>44BF3676-8A53-413D-AD44-41AF5AE1C94C</gtr:id><gtr:title>Allorecognition and the alloresponse: clinical implications.</gtr:title><gtr:parentPublicationTitle>Tissue antigens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a24f02668e536a6d0df0cd985e178d88"><gtr:id>a24f02668e536a6d0df0cd985e178d88</gtr:id><gtr:otherNames>Afzali B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0001-2815</gtr:issn><gtr:outcomeId>1FCE37274D1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F5FF2015-FE36-44DD-A10A-841F578299B9</gtr:id><gtr:title>Translational mini-review series on Th17 cells: induction of interleukin-17 production by regulatory T cells.</gtr:title><gtr:parentPublicationTitle>Clinical and experimental immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a24f02668e536a6d0df0cd985e178d88"><gtr:id>a24f02668e536a6d0df0cd985e178d88</gtr:id><gtr:otherNames>Afzali B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0009-9104</gtr:issn><gtr:outcomeId>B7D9D8AA9EF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E415614F-D60B-4C69-8C1B-E33BCB5EF512</gtr:id><gtr:title>Anemia after renal transplantation.</gtr:title><gtr:parentPublicationTitle>American journal of kidney diseases : the official journal of the National Kidney Foundation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a24f02668e536a6d0df0cd985e178d88"><gtr:id>a24f02668e536a6d0df0cd985e178d88</gtr:id><gtr:otherNames>Afzali B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0272-6386</gtr:issn><gtr:outcomeId>B14E40CC221</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A741F67D-B52C-4125-AA7A-08EC45521D59</gtr:id><gtr:title>CD4+CD25high Foxp3+ regulatory T cells in myelodysplastic syndrome (MDS).</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1b47da750ef442cb5eafd80487cbf4e9"><gtr:id>1b47da750ef442cb5eafd80487cbf4e9</gtr:id><gtr:otherNames>Kordasti SY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>65CF3A2542F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CF83A5D7-8C37-41F5-869B-45A62FA5CF34</gtr:id><gtr:title>Compromise of renal transplant blood flow by an arteriovenous graft.</gtr:title><gtr:parentPublicationTitle>Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8b50a758460376bd49c61213eaaf50d3"><gtr:id>8b50a758460376bd49c61213eaaf50d3</gtr:id><gtr:otherNames>Symington E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0931-0509</gtr:issn><gtr:outcomeId>6B79B879F04</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0A6368E5-45A8-4327-8A64-E680D2BDD62C</gtr:id><gtr:title>Oxford Textbook of Clinical Nephrology</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/95324b8982772deb71f231fbdb59f644"><gtr:id>95324b8982772deb71f231fbdb59f644</gtr:id><gtr:otherNames>Afzali B, Kemper C</gtr:otherNames></gtr:author></gtr:authors><gtr:isbn>978-0198508243</gtr:isbn><gtr:outcomeId>d1PmAyujoSt</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F45E2BB9-A2EC-48AD-95CE-65AA8E8C90AC</gtr:id><gtr:title>Transmission of syphilis by solid organ transplantation.</gtr:title><gtr:parentPublicationTitle>American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/59a10d10be106a684390e8a8e510a9c6"><gtr:id>59a10d10be106a684390e8a8e510a9c6</gtr:id><gtr:otherNames>Cortes NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1600-6135</gtr:issn><gtr:outcomeId>B3B183C9583</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A62FDC2E-DCBE-4D88-9975-CB23F04C3C48</gtr:id><gtr:title>Basic Sciences in Obstetrics and Gynaecology</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8905ecdb398cf8c8f14de0b690860933"><gtr:id>8905ecdb398cf8c8f14de0b690860933</gtr:id><gtr:otherNames>Afzali B, Gokmen R, Makanjuola D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:isbn>978-0443102813</gtr:isbn><gtr:outcomeId>bebqmGRR21U</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0500429</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>